Loading...

RBC Lysis Buffer (10X)

Pricing & Availability
Regulatory Status
RUO
Other Names
Red blood cell lysis buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420301 100 mL 52€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
420302 500 mL 165€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Red Blood Cell (RBC) Lysis Buffer has been designed, formulated, and tested to ensure optimal lysis of RBCs in single cell suspensions with minimal effects on leukocytes. RBC Lysis Buffer is supplied as a 10X solution containing ammonium chloride, potassium carbonate, and EDTA, and should be diluted in deionized water prior to use. Nucleated RBCs are not effectively lysed with ammonium chloride. Test

Product Details
Technical Data Sheet (pdf)

Product Details

Formulation
This red blood cell (RBC) lysis buffer is supplied as a 10X solution and should be diluted to 1X in deionized water. 100 ml of 10X concentrate will yield a quantity of 1X solution that is sufficient to lyse 500 samples.
Preparation
The pH of the 1X solution should fall within the range of pH 7.1-7.4. Adjust the pH if necessary. Warm the 1X solution to room temperature prior to use.
Storage & Handling
Store RBC lysis buffer between 2°C and 8°C.
Application Notes

A. Lysis of Mouse Spleen RBCs:
1. Harvest mouse spleen and prepare a single cell suspension.
2. Pellet the cells by centrifugation (350 x g); aspirate the supernatant.
3. Dilute the 10X Red Blood Cell Lysis Buffer to 1X working concentration with deionized water and resuspend the pellet in 5 ml of 1X Lysis Buffer.
4. Incubate on ice for 4-5 minutes with occasional shaking.
5. Stop the reaction by diluting the Lysis Buffer with 20-30 ml of 1X PBS.
6. Spin the cells (350 x g) and discard the supernatant.
7. Resuspend the pellet in the appropriate buffer (e.g., BioLegend Cell Staining Buffer Cat. No. 420201), wash 1X.
8. Count cells, adjust density, and proceed with cell staining procedures.
B. Lysis of Human Peripheral Blood RBCs:
1. Dilute the 10X RBC Lysis Buffer to 1X working concentration with deionized water. Warm the 1X solution to room temperature prior to use.
2. Add 2.0 ml of 1X RBC Lysis Buffer to each tube containing up to 100 µl of whole blood.
3. Gently vortex each tube immediately after adding the lysing solution. Incubate at room temperature, protected from light, for 10-15 minutes.
4. Centrifuge 350 x g for 5 minutes. Aspirate supernatant without disturbing pellet.
5. Resuspend the pellet in the appropriate buffer (e.g., BioLegend Cell Staining Buffer, Cat. No. 420201), wash 1X.
6. Resuspend and proceed with further procedures.

Application References

(PubMed link indicates BioLegend citation)
  1. Adams RA, et al. 2007. J. Exp. Med. 204:571.
  2. Feild-Corbett C, et al. 2009. Stem Cells. PubMed
  3. de Resende MM, et al. 2010. Physiol Genomics. 42:437. PubMed
  4. Roybal JD, et al. 2011. Mol Cancer Res. 9:25. PubMed
  5. Boldin MP, et al. 2011. J Exp Med. PubMed
  6. Kahlenberg JM, et al. 2011. J. Immunol. 187:6143. PubMed
  7. Deiuliis JA, et al. 2012. Am J Physiol Lung Cell Mol Physiol. 302:399. PubMed
  8. Wu CY, et al. 2012. PLoS One. 7:e42365. PubMed
  9. Hsia BJ, et al. 2012. J Allergy Clin Immunol. 130:205. PubMed
  10. Rico C, et al. 2012. Carcinogenesis. 33:2283. PubMed
  11. Jin J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:2901. PubMed
  12. Saraiva AM, 2013. Hum Immunol. 74:207. PubMed
  13. Koon HW, et al. 2013. J Vis exp. 68:4208. PubMed
  14. Ma Dy, et al. 2013. J Virol. 87:3361. PubMed
  15. Han W, 2013. J. Immunol. 190:4786. PubMed
  16. Garcia-Acros I, et al. 2013. J Biol Chem. 288:14046. PubMed
  17. Zhao JL, et al. 2013. Elife. 21:537. PubMed
  18. Guo W, et al. 2013. J Gerontol A Biol Sci Med Sci. PubMed
  19. Yamasaki S, et al. 2013. Clin Vaccine immunol. 20:1508. PubMed
  20. Kraft P, et al. 2013. Stroke. 44:3202. PubMed
  21. Liu X, et al. 2013. Invest Ophthalmol Vis Sci. 54:7386. PubMed
  22. Fullerton AM, et al. 2013. Toxicol Sci. 136:72. PubMed
  23. Cekic C, et al. 2013. J Exp Med. 210:2693. PubMed
  24. Varga T, et al. 2013. J. Immunol. 191:5695. PubMed
  25. Ma Y, et al. 2014. Cancer Res. 74:436. PubMed
  26. Chang YJ, et al. 2014. Cytotherapy. 16:560. PubMed
  27. Kim MJ, et al. 2014. Mol Pharmacol. 86:284. PubMed
  28. Cekic C, et al. 2014. Cancer Res. 74:7250. PubMed
  29. Szulzewsky F, et al. 2015. PloS One. 10:116644. PubMed
Product Citations
  1. Dobie R, et al. 2020. Cell Reports. 29(7):1832-1847.e8.. PubMed
  2. Strickley JD, et al. 2019. Nature. 575:519. PubMed
  3. Deiuliis J, et al. 2012. Am J Physiol Lung Cell Mol Physiol. 302:L399. PubMed
  4. Jin J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:2901. . PubMed
  5. Barros-Martins J, et al. 2016. J Immunol. 196: 3642 - 3652. PubMed
  6. Zhou B, et al. 2020. Nat Immunol. 1.868055556. PubMed
  7. Tan J, et al. 2021. iScience. 24(8):102835. PubMed
  8. Asem M, et al. 2020. Cancer Res. 1156:80. PubMed
  9. Lin C, et al. 2020. Cancer Immunol Res. 632:8. PubMed
  10. Tsai AG, et al. 2020. Nat Med. 408:26. PubMed
  11. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  12. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  13. Sandovici I, et al. 2022. Dev Cell. 57:63. PubMed
  14. Rathakrishnan A, et al. 2020. Viruses. 12: . PubMed
  15. Wang Y, et al. 2021. Cancer Res. 81:384. PubMed
  16. Wang H, et al. 2022. Nat Biomed Eng. 6:882. PubMed
  17. Yeh PY, et al. 2022. Sens Actuators B Chem. 353: . PubMed
  18. Ammothumkandy A, et al. 2022. Nat Neurosci. 25:493. PubMed
  19. Melendez E, et al. 2022. Development. 149: . PubMed
  20. Argueta LB, et al. 2022. iScience. 25:104223. PubMed
  21. Wang S, et al. 2022. Adv Sci (Weinh). 9:e2201258. PubMed
  22. Meena AS, et al. 2022. Cell Rep. 39:110937. PubMed
  23. Zhang Y, et al. 2022. Vaccines (Basel). 10: . PubMed
  24. Sugimoto S, et al. 2022. Nat Metab. 4:775. PubMed
  25. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  26. Isildar B, et al. 2022. Inflamm Regen. 42:55. PubMed
  27. Xu Q, et al. 2022. Front Med (Lausanne). 9:940554. PubMed
  28. Alexandrou AT, et al. 2022. iScience. 25:105546. PubMed
  29. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  30. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  31. Tratwal J, et al. 2022. Front Endocrinol (Lausanne). 13:1001210. PubMed
  32. Xie Z, et al. 2022. Cell Discov. 8:133. PubMed
  33. Xiang X, et al. 2022. Medicine (Baltimore). 101:e32558. PubMed
  34. Yu Z, et al. 2023. Cancer Res. 83:700. PubMed
  35. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  36. Oh S, et al. 2023. Nat Biotechnol. :. PubMed
  37. Marritt KL, et al. 2023. Front Immunol. 13:1087991. PubMed
  38. He T, et al. 2023. Immun Inflamm Dis. 11:e759. PubMed
  39. Vyas M, et al. 2023. Front Immunol. 13:1098445. PubMed
  40. Li XF, et al. 2023. J Exp Med. 220: . PubMed
  41. Wang J, et al. 2023. Inflamm Regen. 43:12. PubMed
  42. Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed
  43. Feng J, et al. 2022. Immunity. 55:405. PubMed
  44. Rustagi Y, et al. 2022. Diabetes. 71:1149. PubMed
  45. Guennoun R, et al. 2022. Cancers (Basel). 14:. PubMed
  46. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  47. Knelson EH, et al. 2022. Cancer Immunol Res. 10:947. PubMed
  48. Wakiyama H, et al. 2022. Cancer Immunol Res. 10:1386. PubMed
  49. Roweth HG, et al. 2022. Sci Adv. 8:eabo5224. PubMed
  50. Zhong J, et al. 2022. J Adv Res. 41:145. PubMed
  51. Yun HJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  52. Daum P, et al. 2023. Front Immunol. 13:991347. PubMed
  53. Rao D, et al. 2023. Eur J Immunol. 53:e2250258. PubMed
  54. Le DT, et al. 2023. iScience. 26:106059. PubMed
  55. Romo-Rodríguez R, et al. 2023. Arch Med Res. 54:197. PubMed
  56. Mabire M, et al. 2023. Nat Commun. 14:1830. PubMed
  57. MacPherson KP, et al. 2023. Front Cell Neurosci. 17:895017. PubMed
  58. Chen Z, et al. 2023. Nat Commun. 14:1839. PubMed
  59. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  60. Ramalingam P, et al. 2023. Nat Commun. 14:2018. PubMed
  61. Choi YJ, et al. 2023. Nat Commun. 14:2045. PubMed
  62. He Q, et al. 2023. Parasit Vectors. 16:139. PubMed
  63. Pattnaik A, et al. 2023. Vaccines (Basel). 11:. PubMed
  64. Mulcrone PL, et al. 2023. Sci Rep. 13:8436. PubMed
  65. Villalba N, et al. 2023. J Neuroinflammation. 20:127. PubMed
  66. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  67. Matsudaira T, et al. 2023. Commun Biol. 6:665. PubMed
  68. Nguyen, H. P., An, K., et al. 2025. Nat Biotechnol. 43(12),1979-1995. PubMed
  69. Jebbawi, F., Olomski, F., et al. 2025. Allergy. 80(12),3377-3390. PubMed
  70. Xu, L., Paine, A. C., et al. 2025. J Virol. 99(10),e0126125. PubMed
  71. Haykal, T., Yang, R., et al. 2025. Cancer Res. 85(24),4995-5014. PubMed
  72. Li, S., Wang, Y., et al. 2025. Signal Transduct Target Ther. 10(1),323. PubMed
  73. Huang, H., Li, S., et al. 2025. Sci Rep. 15(1),35547. PubMed
  74. Li, Q., de Oliveira Formiga, R., et al. 2025. Nat Metab. 7(12),2510-2530. PubMed
  75. Phoon, Y. P., Wolfarth, A. A., et al. 2025. Sci Rep. 15(1),37950. PubMed
  76. Choi, Y., Shim, M., et al. 2025. Exp Mol Med. 57(11),2487-2504. PubMed
  77. Chen, Y., Liao, Y., et al. 2025. Nat Commun. 16(1),10249. PubMed
  78. Han, C., Yuan, H., et al. 2025. FASEB J. 39(23),e71273. PubMed
  79. Wessel, B. M., Castro, J. N., et al. 2025. Organoids. 4(4),0. PubMed
  80. Qiu, Z., Song, N. J., et al. 2025. J Clin Invest. 0(0),0. PubMed
  81. Lu, W., Jin, T., et al. 2025. Sci Rep. 15(1),44077. PubMed
  82. Izgutdina, A., Rashid, T., et al. 2025. J Immunother Cancer. 13(12),0. PubMed
  83. Herisson F, et al. 2018. Nat Neurosci. 21:1209. PubMed
  84. Shin J, et al. 2020. Hum Gene Ther. . PubMed
  85. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  86. Spengler J, et al. 2016. J Infect Dis. 214: S308 - S318. PubMed
  87. Zheng M, et al. 2016. J Immunol. 196: 4122 - 4131. PubMed
  88. St-Pierre S, et al. 2016. PLoS One. 11: 0150230. PubMed
  89. Ensan S, et al. 2015. Nat Immunol. 17: 159-168. PubMed
  90. Jaiswal M, et al. 2015. Sci Rep. 5: 15221. PubMed
  91. Hou J, et al. 2015. J Mol Cell Biol. 7: 338-350. PubMed
  92. Fujii H, et al. 2015. PLoS One. 10: 0133216. PubMed
  93. Pracht K, et al. 2021. Eur J Immunol. 51:1089. PubMed
  94. Radwanska M, et al. 2020. Methods Mol Biol. 2116:721. PubMed
  95. Rendon CJ, et al. 2022. Front Endocrinol (Lausanne). 13:995499. PubMed
  96. Effern M, et al. 2022. STAR Protoc. 3:101038. PubMed
  97. Della Verde G, et al. 2022. Life Sci Alliance. 5:. PubMed
  98. Su C, et al. 2021. Front Oncol. 11:719564. PubMed
  99. Jacoby E, et al. 2021. NPJ Regen Med. 6:58. PubMed
  100. Chen Z, et al. 2020. Glia. 68:2148. PubMed
  101. Seow JJW, et al. 2021. Front Med (Lausanne). 8:603374. PubMed
  102. Liu W, et al. 2017. Int J Environ Res Public Health. 10.3390/ijerph14060592. PubMed
  103. Pietrocola F, et al. 2017. Autophagy. 0.935416667. PubMed
  104. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  105. Wang J, et al. 2020. Sci Rep. 10:12785. PubMed
  106. Ma Y, et al. 2014. Cancer Res. 74:436. PubMed
  107. Magalhães L, et al. 2015. PLoS Negl Trop Dis. 10: 0003816. PubMed
  108. Moraes-Vieira P, et al. 2016. Diabetes. 65: 1317 - 1327. PubMed
  109. Garcia-Fabiani MB, et al. 2020. STAR Protoc. :1. PubMed
  110. Zhang J, et al. 2021. Aging (Albany NY). 13:17880. PubMed
  111. Press AT, et al. 2021. EMBO Mol Med. 13:e14436. PubMed
  112. Sima LE, et al. 2021. J Immunother Cancer. 9:. PubMed
  113. Ma H, et al. 2021. Front Immunol. 12:760095. PubMed
  114. McGill CJ, et al. 2021. STAR Protoc. 2:100948. PubMed
  115. Lutze J, et al. 2022. Methods Mol Biol. 2394:299. PubMed
  116. Hosseini A, et al. 2022. Evid Based Complement Alternat Med. 2022:5639226. PubMed
  117. Bikorimana JP, et al. 2022. Cell Rep Med. 3:100534. PubMed
  118. Zhang L, et al. 2022. JCI Insight. 7:. PubMed
  119. Baldominos P, et al. 2022. STAR Protoc. 3:101795. PubMed
  120. Boldin M, et al. 2011. J Exp Med. 208:1189. PubMed
  121. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  122. Bravo–San Pedro JM, et al. 2019. Cell Metab. 30:754. PubMed
  123. Clark EL, et al. 2017. PLoS Genet. 13:e1006997. PubMed
  124. Cantor JR, et al. 2017. Cell. 169:258. PubMed
  125. Ji WJ, et al. 2017. Cytometry B Clin Cytom. 92:371. PubMed
  126. Devalaraja S, et al. 2020. Cell. 1098:180. PubMed
  127. Elisabeth Schrumpf, Xiaojun Jiang 2017. Physiol Rep. 10.14814/phy2.13117. PubMed
  128. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  129. Brunmeir R, et al. 2016. PLoS Genet. 12:e1006474. PubMed
  130. Pridans C, et al. 2016. J Immunol. 197: 2297 - 2305. PubMed
  131. Mircheff A, et al. 2016. Ocul Surf. 14:460-483. PubMed
  132. Pennington L, et al. 2016. Nat Commun. 7:11610. PubMed
  133. Koon H, et al. 2012. J Vis Exp. 68: 4208. PubMed
  134. Chen J, et al. 2022. Nat Commun. 13:6759. PubMed
  135. Wu Y, et al. 2021. Nat Biomed Eng. 5:1336. PubMed
  136. Meng S, et al. 2022. Exp Anim. . PubMed
  137. Kokkinopoulos I, et al. 2021. Sci Rep. 11:15759. PubMed
  138. Johnson CL, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H756. PubMed
  139. Stringhini M, et al. 2021. MAbs. 13:1868066. PubMed
  140. Sakamoto S, et al. 2020. OncoImmunology. 8(12):e1671760.. PubMed
  141. Rico C, et al. 2012. Carcinogenesis. 33:2283. PubMed
  142. Hamour S, et al. 2015. PLoS One. 10: 0136238. PubMed
  143. Bazett M, Haston M 2016. Sci Rep. 6:19189. PubMed
  144. Luo B, et al. 2016. J Neurosci. 36: 9590 - 9603. PubMed
  145. Patera A, et al. 2016. J Leukoc Biol. 100(6):1239-1254. PubMed
  146. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  147. Zhai Z, et al. 2021. Medicine (Baltimore). 100:e26214. PubMed
  148. Hu D, et al. 2021. J Cell Mol Med. 25:2900. PubMed
  149. Jones N, et al. 2021. Nat Commun. 12:1209. PubMed
  150. Wang D, et al. 2021. Signal Transduct Target Ther. 6:376. PubMed
  151. Machado H, et al. 2021. PLoS Pathog. 17:e1009933. PubMed
  152. Yan X, et al. 2022. Int J Biol Sci. 18:585. PubMed
  153. Singh SS, et al. 2021. Eur J Med Chem. 216:113312. PubMed
  154. Pokhrel RH, et al. 2022. Int J Mol Sci. 23:. PubMed
  155. Vannini N, et al. 2019. Cell Stem Cell. 24:405. PubMed
  156. Jiang J, et al. 2018. Cancer Med. 3.504861111. PubMed
  157. Chen Z, et al. 2017. Cancer Res. 77:2266. PubMed
  158. Kim M, et al. 2017. Int J Mol Sci. 10.3390/ijms18061275. PubMed
  159. Facchini M, et al. 2014. J Vis Exp. 85: 51019. PubMed
  160. Ilievski V, et al. 2015. PLoS One. 10: 0136502. PubMed
  161. Saraiva A, et al. 2013. Hum Immunol. 74:207. PubMed
  162. Mo L, et al. 2022. Front Oncol. 12:871489. PubMed
  163. Huang L, et al. 2021. J Cell Physiol. 236:7308. PubMed
  164. Whytock KL, et al. 2022. iScience. 25:104772. PubMed
  165. Neufeld L, et al. 2021. Sci Adv. 7:. PubMed
  166. Friedman G, et al. 2020. Nat Cancer. 1:692. PubMed
  167. Kumar A, et al. 2021. Part Fibre Toxicol. 18:43. PubMed
  168. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  169. Scherer SD, et al. 2021. Breast Cancer Res. 23:100. PubMed
  170. Jeong J, et al. 2021. Immune Netw. 21:e31. PubMed
  171. Sitaraman S, et al. 2021. JCI Insight. 6:. PubMed
  172. Orr AN, et al. 2021. Int J Mol Sci. 22:. PubMed
  173. Wang K, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.04.016. PubMed
  174. Appelbe O, et al. 2017. J Control Release.. 10.1016/j.jconrel.2017.09.043. PubMed
  175. Tang J, et al. 2017. Proc Natl Acad Sci U S A. 114:E7441. PubMed
  176. Liccardi G, et al. 2019. Mol Cell. 73:413. PubMed
  177. Patil R, et al. 2019. J Biomed Opt. 24:1. PubMed
  178. Ongaro T, et al. 2020. Oncotarget. 3.026388889. PubMed
  179. Kahlenberg J, et al. 2011. J Immunol. 187:6143. PubMed
  180. Han W, et al. 2013. J Immunol. 190:4786. PubMed
  181. Yamasaki S, et al. 2013. Clin Vaccine Immunol. 20:1508. PubMed
  182. Fukui R, et al. 2016. J Immunol. 196: 416 - 427. PubMed
  183. Rodriguez-Garcia M, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.72. PubMed
  184. Kildisiute G, et al. 2021. Sci Adv. 7: . PubMed
  185. Schiferle EB, et al. 2021. Sci Adv. 7: . PubMed
  186. Devalaraja S, et al. 2020. STAR Protoc. 1:100188. PubMed
  187. Bigenwald C, et al. 2021. Nat Med. 27:851. PubMed
  188. Gingrich AA, et al. 2021. Front Immunol. 12:670309. PubMed
  189. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  190. Deng J, et al. 2021. Breast Cancer Res Treat. 185:85. PubMed
  191. Vivanco Gonzalez N, et al. 2022. STAR Protoc. 3:101280. PubMed
  192. Qin L, et al. 2022. Nat Commun. 13:6051. PubMed
  193. Escudero-Lara A, et al. 2022. Front Behav Neurosci. 16:946975. PubMed
  194. Martínez-Muriana A, et al. 2020. Stem Cell Res Ther. 11:53. PubMed
  195. Pennig J, et al. 2019. Sci Rep. 9:17937. PubMed
  196. Wang B, et al. 2017. Stem Cell Res Ther.. 10.1186/s13287-017-0744-6. PubMed
  197. Anstine L,et al. 2017. J Am Heart Assoc.. 10.1161/JAHA.117.007097. PubMed
  198. Judge SJ, et al. 2020. J Clin Invest. 130:3051. PubMed
  199. Choi JW, et al. 2020. PLoS One. 15:e0235518. PubMed
  200. Alban TJ, et al. 2020. Front Immunol. 1.285416667. PubMed
  201. Jiang S, et al. 2017. Toxicology Lett. 10.1016/j.toxlet.2017.03.015. PubMed
  202. Agrawal V, et al. 2016. J Leukoc Biol. 100: 261 - 274. PubMed
  203. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  204. Evans AK, et al. 2020. Neurobiol Dis. 146:105089. PubMed
  205. Elphinstone R, et al. 2017. Infect Immun. 10.1128/IAI.00371-17. PubMed
  206. Kernfeld EM, et al. 2018. Immunity. 48:1258. PubMed
  207. Nwani NG, et al. 2019. Cancers (Basel). 0.806944444. PubMed
  208. Ramalingam P, et al. 2020. Nat Commun. 11:666. PubMed
  209. Garcia-Arcos I, et al. 2013. J Biol Chem. 288:14046. PubMed
  210. Sci T 2013. Toxicol Sci. 136:72. PubMed
  211. Metz H, et al. 2016. Proc Natl Acad Sci U S A. 113: 8795 - 8800. PubMed
  212. Cheng Q, et al. 2020. Nat Nanotechnol. 0.842361111. PubMed
  213. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  214. Alghamri MS, et al. 2020. Methods Enzymol. 632:215. PubMed
  215. Yu Z, et al. 2021. Front Oncol. 11:659251. PubMed
  216. Deng J, et al. 2021. Nat Cancer. 2:503. PubMed
  217. Beaudoin-Bussières G, et al. 2022. Cell Rep. 38:110368. PubMed
  218. Hu H, et al. 2021. Cancer Immunol Res. 9:1298. PubMed
  219. Zhong W, et al. 2022. Nat Commun. 13:4390. PubMed
  220. So EY, et al. 2021. Am J Physiol Cell Physiol. 321:C569. PubMed
  221. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  222. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  223. Rosenbluth JM, et al. 2020. Nat Commun. 11:1711. PubMed
  224. Ramaswamy G, et al. 2017. Sci Rep. 10.1038/srep45140. PubMed
  225. Lizotte P, et al. 2016. Sci Rep. 6:31745. PubMed
  226. Tavakol DN, et al. 2021. Curr Protoc. 1:e275. PubMed
  227. Ullah I, et al. 2021. Immunity. 54:2143. PubMed
  228. He Y, et al. 2021. Front Immunol. 12:641206. PubMed
  229. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  230. Ercoli G, et al. 2022. Clin Transl Immunology. 11:e1366. PubMed
  231. Meng YM, et al. 2021. Nat Commun. 12:6011. PubMed
  232. Zhu QY, et al. 2021. Nat Commun. 12:6624. PubMed
  233. Patel M, et al. 2021. Cancer Res. 81:3985. PubMed
  234. Shi X, et al. 2021. Nat Commun. 12:2547. PubMed
  235. Wen J, et al. 2017. J Hematol Oncol. 10.1186/s13045-017-0489-9. PubMed
  236. Ahmad S,et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. . 10.1016/j.pnpbp.2017.10.001. PubMed
  237. Hang J, et al. 2019. Cancer Med. 1.254166667. PubMed
  238. Tan X, et al. 2019. Sci Rep. 2.7125. PubMed
  239. Lienemann PS, et al. 2020. Adv Sci (Weinh). 7:1903395. PubMed
  240. Zhao J, et al. 2013. Elife. 21:537. PubMed
  241. Weber G, et al. 2015. Surgery. 158: 248-254. PubMed
  242. Jiang H, et al. 2016. Nat Med. 10.1038/nm.4123. PubMed
  243. Elgueta R, et al. 2016. J Immunol. 197: 3970 - 3981. PubMed
  244. Sharma A, et al. 2020. Cell. 183(2):377-394.e21. PubMed
  245. Hills LB, et al. 2021. J Immunol. 206:89. PubMed
  246. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  247. Pace J, et al. 2022. J Biomed Opt. 27:. PubMed
  248. Pedicona F, et al. 2022. Sci Signal. 15:eabl7989. PubMed
  249. Fidalgo MF, et al. 2022. Life Sci Alliance. 5:. PubMed
  250. Stirling ER, et al. 2022. J Immunother Cancer. 10:. PubMed
  251. Schweppe RE, et al. 2019. Mol Cancer Res. 17:1036. PubMed
  252. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  253. Yang A, et al. 2018. Cancer Discov. 0.525. PubMed
  254. Rentsendorj A, et al. 2017. Brain Behav Immun. 10.1016/j.bbi.2017.08.019. PubMed
  255. Castoldi F, et al. 2020. Cell Death Discov. 0.339583333. PubMed
  256. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  257. Morris C, et al. 2017. MBio. 10.1128/mBio.00036-17. PubMed
  258. Theurl I, et al. 2016. Nat Med. 10.1038/nm.4146. PubMed
  259. Yan Q, et al. 2022. Clin Transl Med. 12:e1084. PubMed
  260. Zhai K, et al. 2021. Nat Cancer. 2:1136. PubMed
  261. Zhao D, et al. 2020. Cancer Discov. 10:1374. PubMed
  262. Dyck S, et al. 2018. J Neuroinflammation. 0.6875. PubMed
  263. Yang YS, et al. 2020. Mol Ther Methods Clin Dev. 17:922. PubMed
  264. Gangwar RS, et al. 2020. Sci Rep. 10:14348. PubMed
  265. Varga T, et al. 2013. J Immunol. 191:5695. PubMed
  266. Samuelson D, et al. 2016. J Immunol. 196: 2655 - 2665. PubMed
  267. Tsao P, et al. 2016. Proc Natl Acad Sci U S A. 113: 8242 - 8247. PubMed
  268. Soncini M, et al. 2016. Proc Natl Acad Sci U S A. 113: E6219 - E6227. PubMed
  269. Yang C, et al. 2016. Sci Rep. 6:34643. PubMed
  270. Nowyhed H, et al. 2017. Sci Rep. 7:40273. PubMed
  271. De Domenico E, et al. 2020. STAR Protoc. 1:100233. PubMed
  272. Wang Z, et al. 2020. Cell Rep. 33:108472. PubMed
  273. Sadik A, et al. 2020. Cell. 1252:182. PubMed
  274. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  275. Ito T, et al. 2021. Nat Commun. 12:2232. PubMed
  276. Hollerbach A, et al. 2021. J Thromb Haemost. . PubMed
  277. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  278. Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
  279. Zhang Y, et al. 2022. Vaccines (Basel). 10: . PubMed
  280. Majumdar D, et al. 2021. Curr Protoc. 1:e216. PubMed
  281. Michelotti TC, et al. 2022. Front Cell Dev Biol. 10:1025240. PubMed
  282. Ren X, et al. 2022. STAR Protoc. 3:101818. PubMed
  283. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  284. Ramachandran P, et al. 2019. Nature. 575:512. PubMed
  285. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  286. Bowers J, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01221. PubMed
  287. Zhang J, et al. 2020. Pain. 161:1381. PubMed
  288. Heim CE, et al. 2020. Nature Microbiology. 5(10):1271-1284. PubMed
  289. Canali S, et al. 2017. Blood. 129(4):405-414. PubMed
  290. Shen X, et al. 2016. Sci Rep. 6:38778. PubMed
  291. Sauter K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G533 - G547. PubMed
  292. Song C, et al. 2015. Blood. 126: 1813 - 1822. PubMed
  293. Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed
  294. Feng D, et al. 2022. Nat Commun. 13:5554. PubMed
  295. Saber M, et al. 2021. J Neurosci Res. 99:1136. PubMed
  296. Xiang Y, et al. 2022. Skelet Muscle. 12:19. PubMed
  297. Yamazaki T, et al. 2021. Oncoimmunology. 10:1962592. PubMed
  298. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  299. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  300. Bichsel C, et al. 2017. Sci Rep. 10.1038/s41598-017-09928-1. PubMed
  301. James M, et al. 2017. J Nucl Med. . 10.2967/jnumed.117.189597. PubMed
  302. Annibaldi A, et al. 2018. Mol Cell. 69:566. PubMed
  303. Hill SJ, et al. 2018. Cancer Discov. 1.308333333. PubMed
  304. Ma D, et al. 2013. J Virol. 87:3361. PubMed
  305. Kraft P, et al. 2013. Stroke. 44:3202. PubMed
  306. Kim M, et al. 2014. Mol Pharmacol. 86:284. PubMed
  307. Cekic C, et al. 2014. Cancer Res. 74:7250. PubMed
  308. Pankova D, et al. 2016. Mol Cancer Res. 14: 287 - 295. PubMed
  309. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  310. Tulasi DY, et al. 2021. Cell Mol Gastroenterol Hepatol. 11:1437. PubMed
  311. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  312. Xue X, et al. 2021. Cent Eur J Immunol. 46:191. PubMed
  313. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  314. Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed
  315. Resende M, et al. 2010. Physiol Genomics. 42:437. PubMed
  316. McLaughlin S, et al. 2019. Nat Commun. 3.795833333. PubMed
  317. Koury J, et al. 2019. PLoS One. 14:e0218670. PubMed
  318. Zhang Z, et al. 2017. Journal of Translational Medicine. 10.1186/s12967-017-1196-6. PubMed
  319. Peng X, et al. 2021. Stem Cell Res Ther. 198:12. PubMed
  320. Linder A, et al. 2020. EMBO J. 39:e105071. PubMed
  321. Muñoz-Ruiz M, et al. 2016. Nat Immunol. 10.1038/ni.3424. PubMed
  322. Chang Y, et al. 2014. Cytotherapy. 16:560. PubMed
  323. Hsia B, et al. 2012. J Allergy Clin Immunol. 130:205. PubMed
  324. Li N, et al. 2022. Nat Commun. 13:7281. PubMed
  325. Soileau AM, et al. 2022. Vet Sci. 9:. PubMed
  326. McClellan BL, et al. 2022. STAR Protoc. 3:101357. PubMed
  327. Governa V, et al. 2022. Proc Natl Acad Sci U S A. 119. PubMed
  328. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  329. Mai CL, et al. 2021. Theranostics. 11:1059. PubMed
  330. Chen P, et al. 2021. Clin Transl Med. 11:e462. PubMed
  331. Mochizuki M,et al. 2017. J Am Heart Assoc. . 10.1161/JAHA.117.005920. PubMed
  332. Roh–Johnson M, et al. 2017. Dev Cell. 43:549. PubMed
  333. Müller C, et al. 2018. Elife. 7:e34985. PubMed
  334. Guo W, et al. 2013. J Gerontol A Biol Sci Med Sci. . PubMed
  335. Liu Y, et al. 2015. Sci Rep. 5: 15134. PubMed
  336. Hodson D, et al. 2016. Proc Natl Acad Sci U S A. 113: 2039-2046. PubMed
  337. Munson D, et al. 2016. Proc Natl Acad Sci U S A. 113: 8272 - 8277. PubMed
  338. Ubellacker J, et al. 2017. Breast Cancer Res. 10.1186/s13058-017-0815-8. PubMed
  339. DU T, et al. 2020. Front Immunol. 1.571527778. PubMed
  340. Trial J, et al. 2020. Geroscience. . PubMed
  341. Cordo' V, et al. 2022. Nat Commun. 13:1048. PubMed
  342. Hallisey M, et al. 2022. STAR Protoc. 3:101163. PubMed
  343. Denoth-Lippuner A, et al. 2021. Cell Stem Cell. 28:2020. PubMed
  344. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  345. Nagree MS, et al. 2022. EMBO Mol Med. 14:e14297. PubMed
  346. Sobecki M, et al. 2022. Cell Stem Cell. 29:1459. PubMed
  347. Denning W, et al. 2011. PLoS One. 6:e16897. PubMed
  348. Weaver J, et al. 2017. Part Fibre Toxicol. 10.1186/s12989-017-0206-4. PubMed
  349. Samuelson D, et al. 2017. PLoS Pathogens. 13(6):e1006426. PubMed
  350. Wong C, et al. 2017. J Immunol. 10.4049/jimmunol.1700397. PubMed
  351. Saber M, et al. 2020. Eur J Neurosci. 52:2791. PubMed
  352. Wu R, et al. 2020. J Immunother Cancer. 8:00. PubMed
  353. Yu H, et al. 2016. Sci Rep. 6:35190. PubMed
  354. Now H, Yoo J 2016. Cell Mol Immunol. 10.1038/cmi.2016.32. PubMed
  355. Bosma M, et al. 2016. Nat Commun. 7: 11314. PubMed
  356. YC S, SJ L 2015. Sci Rep. 5: 12578. PubMed
  357. Szulzewsky F, et al. 2015. PLoS One. 10:116644. PubMed
  358. Wu C, et al. 2012. PLoS One. 7:e42363. PubMed
  359. Visweshwaran SP, et al. 2022. Front Cell Dev Biol. 10:1008898. PubMed
  360. Li Q, et al. 2022. Signal Transduct Target Ther. 7:222. PubMed
  361. Fielding C, et al. 2022. Nat Commun. 13:543. PubMed
  362. Vechetti IJ, et al. 2021. FASEB J. 35:e21644. PubMed
  363. Gupta R, et al. 2020. Cell Stem Cell. 26:527. PubMed
  364. Roybal J, et al. 2011. Mol Cancer Res. 9:25. PubMed
  365. Cekic C, et al. 2013. J Exp Med. 210:2693. PubMed
  366. Barcia Durán JG, et al. 2021. Commun Biol. 4:406. PubMed
  367. Park HJ, et al. 2021. Int J Mol Sci. 22:. PubMed
  368. Cebrian-Silla A, et al. 2021. Elife. 10:. PubMed
  369. Yeini E, et al. 2021. Nat Commun. 12:1912. PubMed
  370. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  371. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  372. Kucykowicz S, et al. 2022. STAR Protoc. 3:101356. PubMed
  373. Kim TW, et al. 2022. Mol Ther Oncolytics. 26:1. PubMed
  374. Kathania M, et al. 2022. Cell Rep. 40:111345. PubMed
  375. Shaashua L, et al. 2022. Nat Commun. 13:6513. PubMed
  376. Field-Corbett C, et al. 2009. Stem Cells. 27:662. PubMed
  377. Zeng Y, et al. 2019. FASEB J. 33:6596. PubMed
  378. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed
  379. Tomas C, et al. 2019. Sci Rep. 9:11464. PubMed
  380. Kim JK, et al. 2019. Bioengineering (Basel). 6:24. PubMed
  381. Alizadeh A, et al. 2018. J Neuroinflammation. 15:53. PubMed
  382. Guo P, et al. 2017. J Clin Invest. 127:4242. PubMed
  383. Tsai SC, et al. 2017. Biomicrofluidics. 11:034122. PubMed
  384. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  385. Erady C, et al. 2021. NPJ Genom Med. 6:04. PubMed
  386. de Silva S, et al. 2020. Cancer Immunol Res. 0.493055556. PubMed
  387. Wan C, et al. 2021. Cancer Res. 81:158. PubMed
  388. Wang X, et al. 2016. J Virol. 90: 10247 - 10258. PubMed
  389. Mohammed R, et al. 2016. Cell Rep. 14:760-771. PubMed
  390. Durward-Diioia M, et al. 2015. Infect Immun . 83: 4759 - 4771. PubMed
  391. Birnie K, et al. 2015. Mol Cancer Res. 13: 1106 - 1118. PubMed
  392. Liu X, et al. 2013. Invest Ophthalmol Vis Sci . 54:7386. PubMed
  393. Roy IM, et al. 2021. Bio Protoc. 11:e4130. PubMed
  394. Alam A, et al. 2022. STAR Protoc. 3:101563. PubMed
  395. Xiang Y, et al. 2022. Exp Mol Med. 54:1011. PubMed
  396. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  397. Guo P, et al. 2022. Nat Cell Biol. 24:99. PubMed
  398. Wahane S, et al. 2021. Sci Adv. 7:. PubMed
  399. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  400. Huang N, et al. 2021. Nat Med. 27:892. PubMed
  401. Song X, et al. 2021. FEBS Open Bio. 11:2453. PubMed

Antigen Details

Cell Type
Tregs
Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 06/10/2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account